INTRODUCTION
DNA topoisomerases are key enzymes that resolve topological problems incurred during the cellular processes of replication, transcription, recombination and chromosome segregation. Based on their mechanism of action, they are classified into two types: type I DNA topoisomerases can break and rejoin one DNA strand at a time, whereas type I1 enzymes work by making reversible breaks in both strands, in a somewhat concerted manner, and by passing another segment of DNA duplex through this transient break (reviewed by Roca, 1995) . Type I topoisomerases work as monomeric and ATP-indepenent enzymes. Based on their common enzymic properties and protein sequence analysis, the type I topoisomerases can be divided into two subtypes : type 1-5' and type 1-3'. 5' topoisomerases are bacterial DNA topoisomerase I and I11 and eukaryotic DNA topoisomerase 111. In contrast to type I-5', type 1-3' topoisomerases bind preferentially to double-stranded DNA, and cleave one of the DNA strands of the duplex by forming a protein-DNA covalent intermediate between a tyrosyl residue and the 3'-phosphate at the break site. This family includes all eukaryotic DNA topoisomerase I enzymes and prokaryotic DNA topoisomerase IV.
The Saccharornyces cereuisiae TOP1 gene is a member of the highly conserved group of type 1-3' topoisomerases (Goto & Wang, 1985; Roca, 1995) . Despite the evidence for involvement of topoisomerase I in essential functions such as transcription and DNA replication, TOPI is not required for growth, and deletion of this gene results in only a modest growth defect. Deletion of TOPI does, however, cause a large increase in mitotic recombination in the tandemly repeated ribosomal DNA arrays, a chromosomal domain that is normally suppressed for recombination (Christman et al., 1988) . Null mutations in the topoisomerase I gene are also not lethal in Schizosaccharomyces pombe (Uemura et al., 1987) or Ustilago maydis (Gerhold et al., 1994) , but are lethal to a developing Drosophila melanogaster embryo (Lee at al., 1993).
Drugs against DNA topoisomerase I, such as camptothecin, have been developed as potential anticancer agents. The cytotoxicity of the drug is due to the conversion of eukaryotic DNA topoisomerase I into a DNA-damaging agent (poison), rather than the inhibition of an essential function (reviewed by Chen & Liu, 1994) . Therefore, although TOP1 is not essential in many fungi, fungal topoisomerase I could still be considered as a potential antifungal drug target. The Candida albicans DNA topoisomerase I enzyme has been recently isolated and characterized (Fostel et al., 1992; Fostel & Montgomery, 1995) . In vitro experiments showed that stabilization by camptothecin of the fungal topoisomerase I cleavage complex requires a concentration 10-fold greater than the minimum concentration of camptothecin needed to enhance nicking by the human topoisomerase I (Fostel et al., 1992) . Conversely, the fungal topoisomerase I is more susceptible to the aminocatechol A-3253 than the human topoisomerase I (Fostel & Montgomery, 1995) . This evidence suggests that there are structural differences between the two enzymes which may allow for the identification of new antifungal agents which target the fungal topoisomerase I and not the human enzyme. T o begin to verify the structural differences of topoisomerase I from fungal pathogens and humans, we characterized TOP1 from C. albicans. Here we report the cloning and sequencing of TOPl, and the use of an inducible/repressible promoter to study the phenotype of gene shut-off. We also demonstrate here that the TOPl gene disruption strain has reduced virulence in a mouse model.
METHODS
Strains. C. albicans strains CAF2-1 (ura3A : : imm434/URA3) and CAT4 (ura3A : : imm434/ura3A : : imm434) were obtained from W. Fonzi (Fonzi & Irwin, 1993) . DNA cloning was carried out in Escherichia cofi XL1-Blue [recAl endAl gyrA96
[F-480dlacZAM15 A(lacZYA-argF)Ul69 deoR recA1 endAl phoA hsdRl7 (r; m: ) supE44 A-thi-1 gyrA96 relA2 ; Gibco-BRL].
Gene cloning and sequencing. The same conditions and primers were used here to amplify a TOPl gene fragment from C. albicans genomic DNA as were described for cloning of the U. maydis TOP1 gene by PCR (Gerhold et af., 1994).
The amplified PCR fragment was subcloned into pT7Blue vector (Novagen), forming plasmid pCaT53. The clone was verified by sequencing. Using this PCR fragment, genomic clones were obtained from a YEpl3-based C. albicans DNA library (Rosenbluh et al., 1985) . A 3138 bp EcoRI fragment isolated from a clone with the largest insert was subcloned into pBC KS( -) (Stratagene), resulting in plasmid pCaT1-R12. The sequence of this DNA fragment from both strands was determined by an ABI373 sequencer.
Construction of plasmids and strains for gene disruption and promoter replacement of Candida TOPI. The 3138 bp EcoRI DNA fragment containing the C. albicans TOP1 gene was subcloned into the EcoRI site of the pBluescript SK( -) plasmid, forming plasmid pSK+TOPl. An 861 bp NcoIEcoRI fragment of the 3'-end of the Candida TOP2 gene was subcloned from pCAT1-R12 into the SmaI site of plasmid pUC19 after it was blunted with Klenow and nucleotide triphosphates, resulting in plasmid pUC19T1. A 646 bp SmaI-EcoRV fragment of the 5'-end of the C. albicans TOP1 gene was subcloned from pCAT1-R12 into the XbaI site of plasmid pUC19T1 after blunting with Klenow and nucleotide triphosphates, forming plasmid pUC19TA. Finally, a blunted BamHI-Bgf I1 fragment of the hisG-URA3-hisG cassette from pCUB6 (Fonzi & Irwin, 1993) was cloned into the BamHI site of pUClSTA, forming plasmid pUC19TAU. Plasmid pUC19TAU was linearized by Hind111 and SacI and used to transform strain CAI4 to replace TOPl. URA3 prototrophs were restreaked on minimal medium and on 5-fluoroorotic acid to identify ura3 auxotrophs typical of strains in which URA3 loopout occurred. Both the primary transformant (CWJ429) and a loopout strain (CWJ431) derived from CW j429 were verified by Southern blot hybridization.
The N-terminal DNA fragment of the TOPl gene (encoding the first 198 amino acids) was amplified by PCR using primers and TOPlN2 (5'-TCAAGCTTGCAACTTCTTCTGCTTC) and cloned into the pT7Blue vector. A. C. albicans promoter induced by maltose and repressed by glucose (MRPI ; 1085 bp without ATG) was also amplified by PCR using primers and MRPl-B1 (5'-ATGGATCCGTCGATCAAGTTACT-TAC) and cloned into the pT7Blue vector. The characterization of MRPl will be described elsewhere (P. Riggle, personal communication). The XbaI-BamHI promoter fragment was subcloned from the pT7Blue vector into the same sites of plasmid pKW16, which is based on a pBluescript plasmid, pSKII, with a URA3 marker at the SacI site, resulting in plasmid pUM2. The BamHI-Hind111 fragment of TOP1 was then subcloned from the pT7Blue vector into the same sites of pUM2, forming plasmid pUMT2. AspI-linearized pUMT2 was transformed into the heterozygous TOP1 gene disruption strain CWJ431. Transformants were selected on a minimal medium containing maltose as sole carbon source. Again transformants were verified by Southern blot hybridization. After verification by Southern analysis, one transformant was designated CW 5477. This strain contained one disrupted, nonfunctional copy of TOPI and one copy of TOP1 under the control of the maltose-inducible promoter, DNA topoisomerase I assays. Glass beads were used to prepare C. afbicans cell extracts as described for S. cerevisiae (Levin et al., 1993) . Cells from a 50 ml culture at late-exponential phase were collected, washed once with protein buffer (50 mM Tris/HCl, pH 7.5; 1 mM EDTA; 0.3 M KCl; lo%, v/v, glycerol; 2 mM PMSF), and resuspended in the same buffer with a volume equal to the volume of the cell pellet. Acidwashed glass beads (2 vols) were added to the suspension. The suspension was vortexed at 4°C for 60 s three times. Supernatant was collected after an additional wash of beads with 1 vol. of the protein buffer and centrifuged at maximum microfuge speed for 20min. The volume of the final clear protein extract was about 1 ml, which was stored at -70 "C for later use. Protein extract was diluted 1: 10 with protein buffer and 1 pl was used in each reaction containing 200 ng supercoiled pUC19 in 20 p1 of the topoisomerase assay buffer (20 mM Tris, pH 7-5; 100 mM KCl; 10 mM EDTA; 50 pg gelatin ml-l) a After 30 min incubation at 30 "C, reactions were stopped with 1 p120 mg proteinase K ml-I and 2 p120 ' / o (w/v) SDS. DNA was examined in a 0.8% agarose gel containing ethidium bromide after incubation at 37 "C for 30 min and extraction with phenol/chloroform.
Virulence test of TOPI-deleted C. atbicans strains. Three serum/SO YO Sabouraud Dextrose Broth (Difco) at 37 "C (Bulawa et al., 1995) . After 1*5,3 or 14 h incubation, cells were examined microscopically.
RESULTS

Cloning of TOP1
Our strategy for cloning the C. albicans TOP2 gene was to identify peptide domains conserved among eukaryotic topoisomerase I genes, to design oligonucleotide primers based on these domains, and to use PCR to amplify the intervening TOPZ DNA fragment from genomic template DNA. The gene fragment recovered was then used to select a full-length gene from a genomic DNA library.
We have successfully used this approach to clone the U . maydis TOP2 gene (Gerhold et al., 1994 albicans TOP2 ORF with highly significant homology to other TOP2 genes (Fig. la) .
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Conditional gene disruption of TOPl
The essentiality of TOP2 has been tested in a variety of organisms. Thus far, it appears not to be essential in some organisms and can be considered a target for poisons rather than inhibitors (Chen & Liu, 1994) . In Predicted TOPl peptide The predicted C. albicans TOP2 protein (Toplp) contains most of the peptide motifs conserved in Toplp from other eukaryotes (Fig. 2a) . Peptide sequence comparison of Toplp revealed that C. albicans Toplp is most closely related to S . cerevisiae Toplp over the entire sequence (58*8O/o identity; see Fig. 2b ). In the conserved region, in close proximity to the tyrosine (residue 738 ; Figs l a and 2b) known to attach transiently to the DNA, the C. albicans enzyme is typified by a methionine rather than the isoleucine or leucine that is found in seven other eukaryotic enzymes. It is unclear whether this difference may lead to differential specificity of the C. albicans enzyme.
Drosophila it is an essential enzyme that affects embryo development (Lee et al., 1993) . To test whether TOP2 is essential in C. albicans, we initiated the disruption of C. albicans TOP2 using the technology and procedure developed by Fonzi & Irwin (1993) .
A gene disruption construct was made by multi-step cloning so that a 1630 bp internal coding sequence (encoding 543 amino acids ; 70 % of the ORF; Fig. l This result suggests that TOP1 may be essential or that TOP1 deletion homozygosity may impair the growth of transformants. Therefore, we attempted another approach, i.e. using a regulatable promoter (Fig. 3) to test the essentiality of the gene.
A maltose-inducible/glucose-repressible promoter ( M R P I ) was cloned into an integrative URA3 plasmid, forming plasmid pUM2. A DNA fragment encoding the N-terminal198 amino acids of Toplp was placed under this promoter (see Methods), resulting in plasmid pUMT2. Integration of the AspI-linearized pUMT2 into a wild-type copy of TOP1 is expected to create a truncated Toplp with only a 54 N-terminal amino acid peptide and a full-length TOP1 under the regulatable promoter. Transformants were selected on a maltose minimal medium and then streaked onto both maltose and glucose media. All the transformants grew on both media. However, some of them grew more slowly than others. The slower growing cells did not develop hyphae on rich medium after extended incubation (data not shown). These cells were subcultured and their morphology was further examined microscopically. Cells cultured in glucose medium were elongated and tended to lyse (Fig. 4a, lower panel) while cells from the maltose medium grew normally (Fig. 4a , upper panel). T o determine whether the slow-growing cells lacked topoisomerase I activity, crude protein extracts were prepared from cells growing in both media and tested for DNA topoisomerase I activity using a supercoiled DNA relaxation assay (Gerhold et al., 1994) .
In order to determine the sensitivity of this assay, protein extracts were diluted tenfold prior to use. Under these conditions, topoisomerae I activity was still detectable in cells grown in maltose, suggesting that the assay has a broad range of sensitivity (data not shown).
No topoisomerase I activity was detectable in the slowgrowing cells growing in medium containing glucose, while the activity was detectable in all cells grown with maltose (Fig. 4b) . Each of the three strains demonstrating maltose-inducible topoisomerase I activity was characterized to verify their genetic construction by Southern hybridization using a 600 bp fragment of the 5'-end of TOP1 (Fig. 4c) . T o further verify that the disruption of TOP1 was specific, Southern hybridization performed using a URA3 probe yielded a band of the expected size thereby ruling out additional integration events (data not shown). The results indicate that C. albicans TOP1 is not essential for cell growth, but depletion of the protein leads to slow growth and a change in cell morphology.
Virulence test of the TOPI-deleted C. albicans strains
The phenotypic change of the Toplp-depleted C. albicans strain indicates that TOP1 may affect the infectious phase of the organism. To test the effect of TOP1 deletion on virulence in an animal model, normal mice were infected with the parental strain (CAF2-l), TOPl heterozygous knockout strain (CW J429), and the strain (CWJ477) with the only existing copy of TOP1 under the maltose-inducible and glucose-repressible promoter. Prior experiments demonstrated that the maltose promoter used for gene deletions was not induced in uiuo in the mouse model, presumably due to the absence of maltose in tissues and serum. Confirmation of the absence of induction of the maltose promoter was seen by placing URA3 under control of the maltose promoter. This resulted in strains that were rapidly cleared from infected mice and as such were avirulent (data not shown). This outcome is similar to the lack of pathogenicity described for uva3 homozygous knockout strains (Kirsch & Whitney, 1991) . Confirmation of TOPl shut-off by the enzyme assay. Top1 p activity from four independent transformants which have the second copy of the gene presumably placed under a regulated promoter while the first copy has been disrupted was tested with the DNA plasmid relaxation assay. Lanes: 1-4, four transformants with the TOPl expression induced by maltose; 6-9, the same transformants as in lanes 1-4, but cultured in glucose, thus repressing TOPl expression. Lanes 3 and 8 show the same result, indicating that this transformant is different from the other three and that the TOPl gene is not placed under the control of the MRPl promoter. Lanes 5 and 10 show a primary transformant in which one of the two alleles of TOP7 was disrupted. The same results were obtained under both repressive and nonrepressive conditions. Lane 1 1 shows the control reaction without the enzyme. (c) Southern hybridization to confirm TOPl disruption and promoter replacement. The DNA was digested with EcoRl and probed with a 600 bp fragment of 5'-end TOP1. Lanes: 1, wild-type (W) TOPIITOPI; 2, disruption of the first TOPl allele with the hisG-CaURA3-hisG cassette; 3-5, same strains used in lanes 6, 7 and 9 in Fig. 4(b) , replacement of the TOPl promoter in the intact second allele with the MRPl promoter by plasmid integration.
Strains were cultured in both glucose and maltose media prior to injection. Since strain CWJ477 clumps and is fragile in glucose medium (Fig. 4a) , it was difficult to determine cell density accurately. The suspension was vigorously vortexed for 30 s, which was sufficient to disrupt the cell clumps but not to lyse the cells, thus allowing accurate counting in the haemocytometer.
The survival curve for mice infected with the three strains indicated that inactivation of one or two copies of TOP1 leads to dramatic attenuation of virulence (Fig.  5 ). There were no survivors after 7 d among mice infected with the parental strain, whereas about 50 % of the mice survived infection with the heterozygous TOP1 knockout strain, CWJ429, at day 11 from maltosecultured cells and at day 13 from glucose-cultured cells. However, only one of nine mice infected with maltosecultured CWJ477 cells had died by day 22, while about 50 % mice infected with glucose-cultured CWJ477 cells survived.
To test whether the reduced virulence of C. albicans ., CWJ429 (TOPlltopl; n = 9); A, CWJ477 (toplltopl; n = 9). remaining mice. Large numbers of c.f.u. were recovered from the kidneys of mice infected with either TOPl/topl or topI/topZ strains ( Table 1) . Results of a repeat experiment were also similar to the primary experiment (data not shown). Therefore, the survival rate of the host did not reflect the clearance of the pathogen or a significant decrease of c.f.u. in the kidneys of the infected host but rather reflected attenuated virulence of the strains.
TOPI-deleted cells have reduced capability to form germ tubes
Although TOP1 -deleted C. albicans cells have reduced virulence, they were recovered from the kidneys of the infected mice. We tested the germ-tube formation of these strains under three different conditions. When cells were grown in maltose medium (induction conditions) and then tested for germ-tube formation, both heterozygous and homozygous top1 strains (CWJ429 and CWJ477) were able to form germ tubes like the wildtype strain (CAF2-1) (data not shown). However, when cells were pre-grown in glucose medium, the homozygous top1 strain (CWJ477) formed germ tubes with decreased frequency at the beginning of the serum induction (1-5 h) (Fig. 6, left panel) . After extended incubation at 37 "C with serum, few germ tubes could be observed in the homozygous top1 strain (Fig. 6, right  panel) . Similar results were also obtained from cells induced with 10 % dialysed serum supplemented with 2% maltose or glucose. All strains could form germ tubes almost equally well in the 10% dialysed serum with maltose ; however, the homozygous disruptant strain formed germ tubes poorly in the 10% dialysed serum with glucose. These results indicate that W. J I A N G a n d OTHERS topoisomerase I plays an important role in germ-tube formation.
TOPI-deleted cells form hyphae in the kidney
Histological examination of the kidneys of mice infected with the homozygous deletion strain (CW 5477) revealed that Candida was found in a hyphal form (Fig. 7) . The characteristics of infection observed in kidneys containing the heterozygous knockout strain (CW 5429) were indistinguishable from CWJ477. At days 7-10 post-infection, kidneys obtained from mice infected with the wild-type Candida (CAF2-1) contained welldefined focal lesions, comprised of hyphal forms, primarily within the renal cortex (data not shown; see Kwon-Chung & Bennett, 1992) . The kidneys infected with the deletion strains exhibited a very different pattern of infection. Renal tissue obtained 10 d postinfection revealed a dilated renal pelvis (Fig. 7a) .
Contained within the urinary space of the renal pelvis was a large mass of Candida hyphae, commonly referred to as a 'fungus ball' (Fig. 7b) . The lack of lymphocytes in the region surrounding the inflammation suggests that this is an acute, suppurative response. Although there were indications of inflammation in the remainder of the renal tissue, no Candida (either yeast or hyphal forms) was observed in these regions.
DISCUSSION
We report here the cloning and characterization of the tions, indicating that TOPZ plays an important role in cellular processes. A similar effect in TOP2 -disrupted cells of S. cereuisiae and U. maydis has also been observed (Thrash et al., 1985; Gerhold et al., 1994) . In S. cerevisiae, deletion of this gene results in a modest growth defect and a large increase in mitotic recombination in the tandemly repeated ribosomal DNA arrays (Christman et al., 1988) . A top1 gene disruption mutant of U . maydis displayed a subtle colouration phenotype evident during cell senescence and a much lower level of mitotic recombination elevation (Gerhold et al., 1994) .
We also showed that the TOPZ deletion strains were deficient in their ability to form germ tubes and to grow in the hyphal form after serum induction in uitro. It is possible that the inability of the conditional knockout to form hyphae in uitro might be due to a general effect on cell viability rather than specifically to the lack of topoisomerase I activity. However, in viuo, clear histological evidence indicated that these same strains grew in the hyphal form in the renal pelvis; at day 10 postinfection it appears that Candida harboured in the kidney is limited to the urinary space with little or no evidence of hyphal growth in the tissues. These in vivo and in vitro observations are difficult to resolve. It is possible that there are additional factors present in the microenvironment of the murine urinary space which promote hyphal growth of these Candida mutants in the kidney. This possibility warrants further investigation.
Injection of TOPZ deletion strains into mice indicates that deletion of one copy of TOP2 causes some attenuation of virulence, while deletion of both copies leads to a more pronounced degree of attenuation. It is possible that these results might be due to the result of a gross general defect in growth, but the combined histological and survival curve data suggest otherwise. Cells which cannot grow in a host (ura3/ura3 mutants; Kirsch & Whitney, 1991) , for example, are simply cleared from the body before ever colonizing tissues. The TOP2 deletion strains are maintained in the kidney for a prolonged period of time (up to 22 d) at quite high levels [ > lo6 c.f.u. (g tissue)-'], and are able, in this environment, to form hyphae. Despite the obvious maintenance of the mutant Candida in the kidney, these strains are very much reduced in their capacity to cause death in infected mice. Similar results were reported recently for other gene disruptions (Bulawa et al., 1995; Becker et al., 1995) . Gene knockout of DNA topoisomerase I in S. cereuisiae (Goto & Wang, 1985; Thrash et al., 1985) , Schiz. pombe (Uemura et al., 1987) and Ustilago (Gerhold et al., 1994) shows that this enzyme is not essential for viability of these fungi. In contrast, topoisomerase I is essential in a developing D. melanogaster embryo (Lee et al., 1993) . Most of the potential drugs against human DNA topoisomerase I are poisons which do not inhibit the enzyme activity. Rather, these drugs damage cellular processes by trapping the putative covalent intermediate of the reaction (reviewed by Chen & Liu, 1994) . We show here that TOPZ is not essential for in vitro growth;
however, its expression is important for normal cellular morphology, germ-tube formation and virulence in a mouse model.
